Recalls

Salmonella outbreak linked to papayas

papaya Salmonella outbreak linked to papayas Caribeña brand Maradol papayas have been linked to an outbreak of salmonella that’s sickened at least 47 people in 12 states, 12 of whom have been hospitalized. One person has died.

San Juan, Texas-based distributor Grande Produce has informed the Food and Drug Administration (FDA) that it is recalling Caribeña brand Maradol papayas after testing by the Maryland Department of Health found the fruit at a retail location tested positive for the strains of Salmonella Kiambu and Thompason found in infected consumers. However, the company has not issued a press release alerting consumers to this recall, so the FDA is advising everyone to avoid Caribeña brand Maradol papayas.

The Centers for Disease Control and Prevention (CDC) has taken the warning further, advising people not to eat any Maradol papayas from Mexico as the FDA continues its trackback investigation. It appears the distribution pattern of Caribeña brand Maradol papayas does not explain all of the illnesses, meaning other companies likely have distributed contaminated Maradol papayas as well.

At this time, the farm(s) producing these papayas appear to only be in Mexico. Additional brands of papayas found to be affected will be announced as information becomes available.

The states involved in the outbreak include Iowa, Kentucky, Louisiana, Maryland, Minnesota, New Jersey, New York, Pennsylvania, Texas, Utah and Virginia.

Most people with Salmonella develop symptoms such as diarrhea, fever and abdominal cramps. The illness usually lasts four to seven days and most people recover without treatment. Symptoms generally develop within 12 to 72 hours after infection.

Complications associated with salmonella infections include diarrhea so severe that the patient needs to be hospitalized. In these patients, the infection can spread from the intestines to the bloodstream, and then to other body sites and can cause death unless the person is treated with antibiotics. Children younger than 5, the elderly, and those with compromised immune systems are more likely to suffer severe infections.

Source: FDA Safety Announcement